More about

Plaque Psoriasis

News
July 31, 2020
1 min read
Save

Stelara approved for pediatric plaque psoriasis

The FDA has expanded approval of Stelara to include the treatment of moderate to severe pediatric plaque psoriasis, Janssen Pharmaceutical announced in a press release.

News
July 22, 2020
1 min read
Save

FDA approves Wynzora cream for plaque psoriasis

Wynzora cream, MC2 Therapeutics’ plaque psoriasis treatment, has been approved by the FDA for once-daily use in adult patients, according to a press release.

News
July 20, 2020
1 min read
Save

Roflumilast cream superior to vehicle in treatment of plaque psoriasis

Roflumilast cream was superior to vehicle cream in attaining Investigator’s Global Assessment status of clear or almost clear at 6 weeks in patients with plaque psoriasis, according to a study in The New England Journal of Medicine.

News
June 19, 2020
1 min read
Save

Sustained long-term improvements reported with ixekizumab for plaque psoriasis

Long-term clinically significant and sustained improvements were seen with ixekizumab treatment in patients with moderate to severe plaque psoriasis, according to a study reported at the American Academy of Dermatology virtual meeting.

News
June 17, 2020
1 min read
Save

Absolute PASI thresholds maintained after certolizumab pegol for plaque psoriasis

Patients dosed with certolizumab pegol for moderate to severe plaque psoriasis achieved and maintained absolute Psoriasis Area and Severity Index thresholds, according to an analysis at the American Academy of Dermatology virtual meeting.

News
June 13, 2020
1 min read
Save

Twice-weekly Enstilar effective maintenance for psoriasis

Twice-weekly Enstilar effective maintenance for psoriasis

Twice-weekly Enstilar Foam was safe and effective as a maintenance treatment for plaque psoriasis, according to a study presented at the American Academy of Dermatology virtual meeting.

News
June 10, 2020
1 min read
Save

Enrollment complete in tapinarof safety study for plaque psoriasis

Dermavant Sciences has completed enrollment in a long-term safety study of tapinarof for treatment of plaque psoriasis, the company announced in a press release.

News
May 08, 2020
2 min read
Save

Biologic dose reduction fails to demonstrate noninferiority to usual care in psoriasis

A dose reduction schedule of biologics did not show noninferiority to the standard of care based on Psoriasis Area and Severity Index; however, quality of life scores did show noninferiority, according to a clinical trial.

News
April 23, 2020
3 min read
Save

Brodalumab shows low rate of malignancy in psoriasis treatment

Brodalumab, an anti-interleukin-17 receptor A monoclonal antibody used to treat adults with moderate to severe plaque psoriasis, was shown to have low rates of malignancy, according to findings published in American Journal of Clinical Dermatology.

News
April 16, 2020
1 min read
Save

Optimal therapeutic dose protocol may result in more effective psoriasis laser treatment

An optimal therapeutic dose protocol with excimer laser for the treatment of plaque psoriasis yielded more effective dosing in fewer treatment sessions, according to a study.

View more